ASX 200 rises, Costa smashed, Fisher & Paykel drops

The S&P/ASX 200 Index (ASX:XJO) slightly rose today, the Costa Group Holdings Ltd (ASX:CGC) share price was smashed.
The post ASX 200 rises, Costa smashed, Fisher & Paykel drops appeared first on The Motley Fool Australia. –

The S&P/ASX 200 Index (ASX: XJO) went up by 0.03% today to 7,095 points.

Here are some of the highlights from the ASX:

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)

The Fisher & Paykel Healthcare share price fell by 6% after the business reported its FY21 result and also gave some commentary about FY22.

FY21 total operating revenue rose 56% to $1.97 billion, with hospital operating revenue growing 87% to $1.5 billion. However, homecare operating revenue only went up 2%.

This led to net profit after tax going up 82% to $524.2 million. The ASX 200 share’s board decided to implement a 42% increase of the final dividend to 22 cents per share.

Given the wide range of scenarios and uncertainties, the company didn’t give guidance but instead made some observations. It said that a global vaccine rollout during FY22 is likely to reduce global hospitalisations requiring respiratory support for COVID-19 compared to FY21.

It also said that its customers’ stocking and de-stocking choices in response to the pandemic are likely to vary over time. The gross margin is likely to be impacted with freight costs likely to remain elevated and air freight a higher proportion of freight. Fisher & Paykel also said it expects to retain its COVID-19 safety practices on its manufacturing sites.

In the financial year so far, hospital revenue continues to remain variable with higher volume of hospital hardware and consumables to locations with hospitalisation surges and an ongoing shift towards Optiflow nasal high flow therapy. OSA shows signs of recovery after a slower fourth quarter.  

Costa Group Holdings Ltd (ASX: CGC)

The Costa share price was smashed by around 24% today after giving a trading update about its different operating segments.

Overall, the 2021 first half performance is expected to be marginally ahead of the comparable period in 2020, with strong international operations offset by challenges in domestic produce conditions.

In its international segment it’s well progressed with its harvests in both China and Morocco. The ASX 200 share said performance has been very positive versus the previous year and expectations.

In China, although volumes were initially slightly down due to late flowering, the yield is expected to finish in line with the company’s expectations. Management said there has been strong pricing and demand over the season.

Costa said that in Morocco, early season plantings in Agadir as well as earlier season higher volumes across its northern farms together with “generally strong” pricing has seen the business perform well, although ongoing supply chain and COVID-19 related costs have had an impact.

However, the ASX 200 share’s international segment is going to be impacted in the reported result by the higher Australian dollar.

Domestically, there is a mixed performance. Overall mushroom demand remains strong, but mushroom production at Monarto has been impacted by short-term labour constraints.

Avocado volumes and quality have been pleasing and export volumes continue to grow. However, it has seen recent pricing pressure due to increased haas variety production across the sector resulting in reduced pricing compared to last year. It is likely this pricing trend will continue into the second half of the year as increased volume is expected to be delivered across the industry.

Current half performance has been impacted by hail damage and fruit fly restrictions. Costa explained that the 2021 calendar year is an ‘on year’ in terms of yield and it is expected that results in the second half of the year, where the bulk of harvest occurs, will benefit from strong yields.

In tomatoes, whilst it has seen some short-term pricing pressure arising from increased tomato supply, this currently abating and pricing is improving.

It was the worst performer in the ASX 200.

Gentrack Group Ltd (ASX: GTK)

The Gentrack share price went up around 15% today in response to the company releasing its FY21 half-year result.

It said that revenue increased 0.7% year on year to $51 million. Earnings before interest, tax, depreciation and amortisation (EBITDA) increased 63.2% to $7 million. However, the business reported a statutory net loss of $1.1 billion.

Revenue was down in the airport business by $2.1 million due to the industry downturn, but annual recurring revenue (ARR) rose 5.8%.

The business reduced costs by 5% due to cost saving measures. That assisted in the $5.6 million cash generation for the period. It ended with net cash of $22.4 million.

It’s now expecting FY21 EBITDA to be around $5 million and revenue to be similar to FY20 of $100.5 million. Gentrack is expecting to be net cashflow positive.

Learn where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

ASX tech shares roar higher, puts ASX 200 index in the shade

The Costa Group (ASX:CGC) share price is down 22%. Could it be a buy?
The RBNZ could hike rates in 2022. Will the RBA follow suit?

Why ALS, Costa, Fisher & Paykel Healthcare, & Ramsay shares are falling

Here’s why the Gentrack (ASX:GTK) share price is rocketing 14% higher

The post ASX 200 rises, Costa smashed, Fisher & Paykel drops appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!